Posts for Ticker ‘ADLR’

Top Pre-Market Analyst Downgrades (ADLR, MDRX, CRDN, CAG, IFF, MFE, TWX, VRTX, VOD, WWWW)

These are some of the top analyst downgrades and negative calls we are seeing this Wednesday morning:

  • Adolor (ADLR) Cut to Neutral at Piper Jaffray.
  • Allscripts (MDRX) Cut to Neutral at Piper Jaffray.
  • Ceradyne (CRDN) Cut to Underperform at Wachovia.
  • ConAgra (CAG) Cut to Neutral at JPMorgan.
  • International Flavors (IFF) Started as Underweight at Lehman.
  • McAfee (MFE) Cut to Underperform at FBR.
  • Time Warner Inc. (TWX) Cut to Market Perform at Bernstein.
  • Vertex (VRTX) Cut to Perform at Oppenheimer.
  • Vodafone plc (VOD) Cut to Neutral at Credit Suisse.
  • Web.com (WWWW) Cut to Market Perform at FBR.

Jon C. Ogg
September 3, 2008

Posted on: September 3, 2008 – 7:06 am in Analyst Calls, , , , , , , , , ,

Short Selling Volatile Biotechs (June 2007) (DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO)

Stock Tickers: DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO

Many of the recent biotech implosions are always interesting to see if short sellers are getting out of the way or adding pressure.  Out of the biotechs we covered with recent implosions here is what we saw from May to June.  Oddly enough, only Dendreon (DNDN) out of this group showed a drop in the short interest out of this group from May to June..

Dendreon (DNDN)…can’t forget them. Recently we noted how options were weighing on the stock and how the company probably had a news vacuum coming up.
June Short Interest: 40.8 million shares, down almost 2% from May.
May Short Interest: 41.66M.

Adolor Corp. (ADLR)
June Short Interest: 6.5 million shares, up almost 10% from May.
May Short Interest: 5.9 million shares.

Allos Therapeutics (ALTH) didn’t implode, but it looked like it was going to.  Short sellers didn’t have the news ahead of time so maybe the short-covering was a savior.
June Short Interest: 5.17 million shares, up 30% from May.
May Short Interest: 3.97 million shares.

Northfield Labs (NFLD)….going, going, gone…..Biotech Zombie.
June Short Interest: 8.06 million shares, up 8% from May.
May Short Interest:  7.4 million shares.

Nastech Pharma (NSTK) was Cramer’s biotech zombie he said was looking up back in March. Short sellers bet against Cramer.
June Short Interest: 5.09 million shares, up 21% from May.
May Short Interest: 4.2 million shares.

Coley Pahrmaceuticals (COLY)….short sellers didn’t know this was getting the bad news at the cut-off date.
June Short Interest: 4.7 million shares, up 5% from May.
May Short Interest: 4.46 million shares.

Cell Genesys (CEGE)
June Short Interest: 15.4 million shares, up almost under 10% from May.
May Short Interest: 14 million shares.

Nuvelo Inc. (NUVO)…short sellers didn’t know for sure that Bayer was bailing here…..
June Short Interest: 8.06 million shares, up 8% from May.
May Short Interest: 7.44 million shares.

The Biotech HOLDRs (BBH) are hard to draw an inference to because of the size differentials and volume, but its June short interest was up more than 4% from May with a reading of 1.72 million shares.

Jon C. Ogg
June 27, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 27, 2007 – 12:36 pm in Biotech, Short Interest, , , , , , , ,

Pre-Market Stock News (June 11, 2007)

(ADLR) Adolor said a complete response to the POI ‘Approvable’ Letter now targeted for 3Q 2007.
(ALXN) Alexion Pharm says studies show efficacy and safety of it’s Soliris in broad population of PNH patients in Phase III studies examining Soliris for the treatment of paroxysmal nocturnal hemoglobinuria.
(BYBI) Backyard Burgers agrees to be acquired for $6.50 cash per share.
(CHINA) CDC Corp making a gaming company acquisition.
(CSGS) CSG Systems is paying $23.5M cash to acquire private ComTec.
(CUP) Peru Copper gets a friendly takeover offer from Aluminum of China.
(EME) EMCOR raised guidance and announced a 2-1 stock split.
(ENDO) Endo pharmaceuticals’ FROVA Phase III study data showed short-term prevention treatment reduces frequency and severity of menstrual migraine.
(ERIC) Ericsson in GSM expansion pact with China Mobile.
(GERN) Geron says research indicates its embryonic stem cell based therapy for spinal cord injury evades direct attack response by the human immune system.
(GOOG) Google announced search and ad pact with Sina in China.
(GOL) Gol Intelligent Airlines said Continental will sell its tickets for travel to Brazil and South America.
(IBM) IBM paying close to $750 million to acquire Telogic AB in Sweden.
(IMCL) Imclone said FDA accepted and granted priority review of ERBITUX sBLA for overall survival in patients with advanced colorectal cancer.
(JOSB) Jos. A. Bank $0.45 EPS vs $0.42e.
(MDVN) Medivation’s Dimebon maintains statistically significant benefit on all five efficacy endpoints in Alzheimer’s disease after one year of therapy
(NGA) North American Galvanizing trades ex-split to reflect a 3-2 stock split.
(NRMX) Neurochem presents update on Alzhemed, but said that no predictions or conclusions can yet be made regarding the outcome of the Phase III study.
(OI) Owen-Illinois is selling its plastics unit to rexam for $1.8 Billion.
(OSUR) OraSure received a CE mark of approval from the EU for its OraQuick rapid HIV test.
(PRGS) Progress Software added one of the Dow Jones news feeds to its algorithmic trading platform.
(PRW) Pro-Pharmaceutical submits data to begin a 505B2 filing with FDA for new formulation of Irinotecan for potential cancer treatment indications.
(RIMG) Rimage announced a $6.5M order from new major national retail customer.
(SINA) Sina in strategic search and ad partnership with Google in China.
(TRLG) True Religion CEO reduced holdings of 2.3 million shares in a private placement.

Jon C. Ogg
June 11, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 11, 2007 – 6:48 am in Pre-Market Activity, , , , , , , , , , , , , , , , , , , ,